(Minneapolis, MN and Minnetonka, MN - February 22, 2013) Respithera, LLC., and Minnetonka Medical Technology Inc., today announced that they have agreed to collaborate to develop respiratory support products incorporating minimally invasive neuromodulation technologies using concepts and patents owned by Respithera, and patient cardiovascular monitoring and diagnosis technologies using concepts and patents owned by Minnetonka Medical Technology Inc.
About Respithera, LLC:
Respithera develops innovative products that support respiration. Our products aim to reduce serious complications associated with the use of mechanical ventilators and shorten time to recovery. Respithera is an early growth stage company with headquarters in Minneapolis, Minnesota. For more information about Respithera, visit our website at www.respithera.com
About Minnetonka Medical Technology Inc.
Minnetonka Medical Technology, Inc. develops and integrates leading edge technologies for the critical care environment. We integrate these technologies to create next generation products that will technologically lead the market and reduce cost. Minnetonka Medical Technology Inc. is located in Minnetonka, Minnesota.
For more information about Minnetonka Medical Technology Inc., visit our website at www.mmtmed.com
